Latest Insider Transactions at Harmony Biosciences Holdings, Inc. (HRMY)
This section provides a real-time view of insider transactions for Harmony Biosciences Holdings, Inc. (HRMY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Harmony Biosciences Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Harmony Biosciences Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 05
2024
|
Valor Iv Pharma Holdings, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
600,000
-8.31%
|
$18,000,000
$30.3 P/Share
|
|
Nov 05
2024
|
Marshman Fund Trust Ii > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
600,000
-9.02%
|
$18,000,000
$30.3 P/Share
|
|
Nov 01
2024
|
Valor Iv Pharma Holdings, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,000,000
-35.66%
|
$120,000,000
$30.3 P/Share
|
|
Nov 01
2024
|
Marshman Fund Trust Ii > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,000,000
-37.55%
|
$120,000,000
$30.3 P/Share
|
|
Oct 29
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
21,496
-100.0%
|
$859,840
$40.47 P/Share
|
|
Oct 29
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
21,496
+50.0%
|
$515,904
$24.0 P/Share
|
|
Oct 03
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
36,357
-99.03%
|
$1,272,495
$35.33 P/Share
|
|
Oct 01
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
400
-100.0%
|
$16,000
$40.19 P/Share
|
|
Oct 01
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+50.0%
|
$9,600
$24.0 P/Share
|
|
Sep 30
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
23,643
-39.41%
|
$945,720
$40.0 P/Share
|
|
Sep 30
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
95,846
+50.0%
|
$1,150,152
$12.0 P/Share
|
|
Sep 30
2024
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
32,052
-53.42%
|
$1,282,080
$40.0 P/Share
|
|
Sep 30
2024
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+50.0%
|
-
|
|
Sep 30
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
35,846
-100.0%
|
$1,433,840
$40.03 P/Share
|
|
Sep 27
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
200
-100.0%
|
$8,000
$40.05 P/Share
|
|
Sep 27
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+50.0%
|
$4,800
$24.0 P/Share
|
|
Mar 29
2024
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,013
-53.42%
|
$264,429
$33.58 P/Share
|
|
Mar 29
2024
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
-
|
|
Mar 15
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,979
-100.0%
|
$383,328
$32.0 P/Share
|
|
Mar 15
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,979
+50.0%
|
$95,832
$8.22 P/Share
|
|
Mar 08
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
194
-100.0%
|
$6,208
$32.0 P/Share
|
|
Mar 08
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
194
+50.0%
|
$1,552
$8.22 P/Share
|
|
Mar 29
2023
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,414
-51.38%
|
$508,662
$33.36 P/Share
|
|
Mar 29
2023
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
-
|
|
Dec 14
2022
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect |
2,834
-0.11%
|
$167,206
$59.96 P/Share
|
|
Dec 14
2022
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
130
-0.01%
|
$7,800
$60.0 P/Share
|
|
Dec 13
2022
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
6,320
-0.29%
|
$379,200
$60.13 P/Share
|
|
Dec 12
2022
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
22,391
-1.03%
|
$1,343,460
$60.36 P/Share
|
|
Dec 09
2022
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect |
9,847
-0.38%
|
$580,973
$59.89 P/Share
|
|
Dec 08
2022
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect |
36,878
-1.41%
|
$2,175,802
$59.9 P/Share
|
|
Dec 07
2022
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect |
64,026
-2.38%
|
$3,841,560
$60.35 P/Share
|
|
Dec 05
2022
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
77,853
-3.45%
|
$4,749,033
$61.23 P/Share
|
|
Dec 02
2022
|
Andrew Serafin CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
38,000
-98.79%
|
$2,280,000
$60.41 P/Share
|
|
Dec 02
2022
|
Andrew Serafin CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
38,000
+50.0%
|
$304,000
$8.22 P/Share
|
|
Dec 01
2022
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect |
65,652
-2.39%
|
$3,939,120
$60.0 P/Share
|
|
Nov 30
2022
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect |
42,667
-1.53%
|
$2,474,686
$58.93 P/Share
|
|
Nov 29
2022
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect |
21,333
-0.76%
|
$1,215,981
$57.82 P/Share
|
|
Nov 22
2022
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect |
31,902
-1.12%
|
$1,818,414
$57.6 P/Share
|
|
Nov 21
2022
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect |
24,898
-0.87%
|
$1,419,186
$57.08 P/Share
|
|
Nov 18
2022
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect |
20,800
-0.72%
|
$1,185,600
$57.0 P/Share
|
|
Nov 15
2022
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
10,961
-0.48%
|
$657,660
$60.1 P/Share
|
|
Nov 15
2022
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect |
62,933
-2.13%
|
$3,524,248
$56.8 P/Share
|
|
Nov 14
2022
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
40,317
-1.75%
|
$2,378,703
$59.1 P/Share
|
|
Nov 14
2022
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect |
58,667
-1.95%
|
$3,402,686
$58.7 P/Share
|
|
Nov 11
2022
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect |
36,800
-1.21%
|
$2,097,600
$57.14 P/Share
|
|
Nov 10
2022
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
95,242
-3.97%
|
$5,524,036
$58.8 P/Share
|
|
Nov 09
2022
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
15,301
-0.63%
|
$887,458
$58.05 P/Share
|
|
Nov 08
2022
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
18,865
-0.77%
|
$1,131,900
$60.01 P/Share
|
|
Nov 04
2022
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
157,950
-6.09%
|
$9,161,100
$58.81 P/Share
|
|
Nov 03
2022
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
254,141
-8.93%
|
$14,994,319
$59.44 P/Share
|